Abiopharma

🔍 Gies Larry (Executive)

Company: Madison Air Solutions Corp (MAIR)

Report Date: 2026-08-25

Detailed Transactions and Holdings:

• Acquired 12,014,417 shares of Class A common stock at $24.97 per share (Direct)
  Date: 2026-08-25 | Code: A | equity_swap_involved: false | shares_owned_after: 12,014,417.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 12,815,378 shares of Class A common stock at $24.97 per share (Direct)
  Date: 2026-08-25 | Code: A | equity_swap_involved: false | shares_owned_after: 12,815,378.00 | transaction_form_type: 4 | Footnotes: F1, F3

Footnotes:

• F1: The reported transaction represents a purchase from the Issuer pursuant to a securities purchase agreement with certain institutional accredited investors, expected to close on September 1, 2026.
• F2: The reported securities are held in Mr. Gies' revocable trust. Mr. Gies disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
• F3: The reported securities are held directly by Madison Solutions LLC ("Madison Solutions"). As the sole manager of Madison Solutions, Mr. Gies may be deemed to beneficially own the reported securities held directly by Madison Solutions but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
• REMARKS: Madison Solutions and Madison Industries Holdings LLC may be directors-by-deputization solely for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.